Tumour model

NCI-H292

Mucoepidermoid carcinoma, NSCLC
XenograftIn vitro

NCI-H292 cells

Human NCI-H292 cells were isolated from the lung of a patient with lung Lung mucoepidermoid
carcinoma.

Tumour growth in vivo

The cells were collected from a tissue culture flask and injected subcutaneously in the right flank of SCID-CB17 mice. The resulting tumours were monitored by measuring two diameters with calipers, and extrapolating the volume to a sphere.
The mice bearing NCI-H292 tumours can be treated by intra-peritoneal, intra-venous, intratumoral or subcutaneous injection of the compounds. Per os administration is also possible.

Figure 1: (View PDF)
Tumour growth curve of the NCI-H292 cells as xenograft Mean ± SEM (n=3; take rate 100%)

Download PDF

Model characteristics

Organism
Human
Tissue of origin
Lung
Pathology
Mucoepidermoid carcinoma, NSCLC
Model type
In vitro, Xenograft
Availability
Off the shelf (time of expansion)

Request this model

Tell us about your compound and your endpoints. Our team confirms feasibility, timelines and study design before any commitment.

Related models

Other models sharing the same tissue of origin.

Model
Organism
Tissue of origin
Pathology
Type
Rat
Lung
SyngeneicIn vitro

GCT

Human
Lung
Undifferentiated pleomorphic sarcoma
XenograftIn vitro
Human
Lung
Adenocarcinoma
XenograftIn vitro
Human
Lung
Lung adenocarcinoma
XenograftIn vitro
Human
Lung
Carcinoma
XenograftIn vitro
Rat
Lung
SyngeneicIn vitro